Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity - Institut Gustave Roussy Accéder directement au contenu
Article Dans Une Revue EMBO Molecular Medicine Année : 2020

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

Gökhan Yigit
  • Fonction : Auteur
  • PersonId : 1107830
Janine Altmüller
  • Fonction : Auteur
  • PersonId : 1019282
Tuan Zea Tan

Résumé

Functional studies giving insight into the biology of circulating tumor cells (CTCs) remain scarce due to the low frequency of CTCs and lack of appropriate models. Here, we describe the characterization of a novel CTC-derived breast cancer cell line, designated CTC-ITB-01, established from a patient with metastatic estrogen receptor-positive (ER+ ) breast cancer, resistant to endocrine therapy. CTC-ITB-01 remained ER+ in culture, and copy number alteration (CNA) profiling showed high concordance between CTC-ITB-01 and CTCs originally present in the patient with cancer at the time point of blood draw. RNA-sequencing data indicate that CTC-ITB-01 has a predominantly epithelial expression signature. Primary tumor and metastasis formation in an intraductal PDX mouse model mirrored the clinical progression of ER+ breast cancer. Downstream ER signaling was constitutively active in CTC-ITB-01 independent of ligand availability, and the CDK4/6 inhibitor Palbociclib strongly inhibited CTC-ITB-01 growth. Thus, we established a functional model that opens a new avenue to study CTC biology.
Fichier principal
Vignette du fichier
EMBO Mol Med - 2020 - Koch - Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity.pdf (3.44 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03602489 , version 1 (09-03-2022)

Licence

Paternité

Identifiants

Citer

Claudia Koch, Andra Kuske, Simon A. Joosse, Gökhan Yigit, George Sflomos, et al.. Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO Molecular Medicine, 2020, 12 (9), pp.e11908. ⟨10.15252/emmm.201911908⟩. ⟨hal-03602489⟩
102 Consultations
58 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More